Eurofins Scientific SE (ERFSF)
USD 64.5
(-0.77%)
USD 64.5
(-0.77%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.88 Billion EUR | 24.99% |
| 2022 | 3.11 Billion EUR | 24.46% |
| 2021 | 2.5 Billion EUR | -14.29% |
| 2020 | 2.91 Billion EUR | -5.5% |
| 2019 | 3.08 Billion EUR | 11.59% |
| 2018 | 2.76 Billion EUR | 66.43% |
| 2017 | 1.66 Billion EUR | 24.0% |
| 2016 | 1.34 Billion EUR | -10.44% |
| 2015 | 1.49 Billion EUR | 134.55% |
| 2014 | 638.05 Million EUR | -4.32% |
| 2013 | 666.87 Million EUR | 74.1% |
| 2012 | 383.03 Million EUR | -4.4% |
| 2011 | 400.66 Million EUR | 67.89% |
| 2010 | 238.64 Million EUR | 145.31% |
| 2009 | 97.28 Million EUR | -63.12% |
| 2008 | 263.8 Million EUR | 623.14% |
| 2007 | 36.48 Million EUR | -38.21% |
| 2006 | 59.03 Million EUR | -18.17% |
| 2005 | 72.14 Million EUR | 61.35% |
| 2004 | 44.71 Million EUR | 23.9% |
| 2003 | 36.08 Million EUR | -10.42% |
| 2002 | 40.28 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 2.9 Billion EUR | 0.0% |
| 2023 Q4 | 3.88 Billion EUR | 0.0% |
| 2023 FY | 3.88 Billion EUR | 24.99% |
| 2023 Q2 | 3.12 Billion EUR | 0.0% |
| 2022 Q4 | 3.11 Billion EUR | 0.0% |
| 2022 Q2 | 3.08 Billion EUR | 0.0% |
| 2022 FY | 3.11 Billion EUR | 24.46% |
| 2021 Q2 | 2.52 Billion EUR | 0.0% |
| 2021 FY | 2.5 Billion EUR | -14.29% |
| 2021 Q4 | 2.5 Billion EUR | 0.0% |
| 2020 Q2 | 2.93 Billion EUR | 0.0% |
| 2020 FY | 2.91 Billion EUR | -5.5% |
| 2020 Q4 | 2.91 Billion EUR | 0.0% |
| 2019 Q4 | 3.08 Billion EUR | 0.0% |
| 2019 Q2 | 2.66 Billion EUR | 0.0% |
| 2019 FY | 3.08 Billion EUR | 11.59% |
| 2018 Q4 | 2.76 Billion EUR | 0.0% |
| 2018 FY | 2.76 Billion EUR | 66.43% |
| 2018 Q2 | 1.67 Billion EUR | 0.0% |
| 2017 Q2 | 1.31 Billion EUR | 0.0% |
| 2017 Q4 | 1.66 Billion EUR | 0.0% |
| 2017 FY | 1.66 Billion EUR | 24.0% |
| 2016 Q2 | 1.36 Billion EUR | 0.0% |
| 2016 Q4 | 1.34 Billion EUR | 0.0% |
| 2016 FY | 1.34 Billion EUR | -10.44% |
| 2015 Q2 | 1.08 Billion EUR | 0.0% |
| 2015 FY | 1.49 Billion EUR | 134.55% |
| 2015 Q4 | 1.49 Billion EUR | 0.0% |
| 2014 FY | 638.05 Million EUR | -4.32% |
| 2014 Q4 | 638.05 Million EUR | 0.0% |
| 2014 Q2 | 790.85 Million EUR | 0.0% |
| 2013 Q2 | 438.06 Million EUR | 0.0% |
| 2013 FY | 666.87 Million EUR | 74.1% |
| 2013 Q4 | 666.87 Million EUR | 0.0% |
| 2012 Q2 | 389.19 Million EUR | 0.0% |
| 2012 Q4 | 383.03 Million EUR | 0.0% |
| 2012 FY | 383.03 Million EUR | -4.4% |
| 2011 Q3 | 398.86 Million EUR | 28.68% |
| 2011 Q4 | 400.66 Million EUR | 0.45% |
| 2011 Q1 | 311.05 Million EUR | 30.34% |
| 2011 Q2 | 309.96 Million EUR | -0.35% |
| 2011 FY | 400.66 Million EUR | 67.89% |
| 2010 FY | 238.64 Million EUR | 145.31% |
| 2010 Q4 | 238.64 Million EUR | -1.63% |
| 2010 Q2 | 83.59 Million EUR | -60.66% |
| 2010 Q1 | 212.47 Million EUR | 118.41% |
| 2010 Q3 | 242.6 Million EUR | 190.23% |
| 2009 Q4 | 97.28 Million EUR | 0.0% |
| 2009 FY | 97.28 Million EUR | -63.12% |
| 2008 FY | 263.8 Million EUR | 623.14% |
| 2007 FY | 36.48 Million EUR | -38.21% |
| 2006 FY | 59.03 Million EUR | -18.17% |
| 2005 FY | 72.14 Million EUR | 61.35% |
| 2004 FY | 44.71 Million EUR | 23.9% |
| 2003 FY | 36.08 Million EUR | -10.42% |
| 2002 FY | 40.28 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -64824900.0% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | -299665.552% |
| Biocept, Inc. | 10.37 Million USD | -37389.157% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | -7480.689% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | -6252.764% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -711840.167% |
| iMD Companies, Inc. | 1.1 Million USD | -352316.401% |
| IDenta Corp. | 428.17 Thousand USD | -908288.139% |
| Interpace Biosciences, Inc. | 4.24 Million USD | -91568.631% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | -1399000.719% |
| NovelStem International Corp. | 3.32 Million USD | -116891.553% |
| Optigenex Inc. | 4.42 Million USD | -87757.265% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | -238373.329% |
| Response Genetics, Inc | 4.91 Million USD | -78987.027% |
| Rennova Health, Inc. | 359.19 Thousand USD | -1082744.042% |
| RushNet, Inc. | 4.25 Million USD | -91366.232% |
| ScreenPro Security Inc. | 249.05 Thousand USD | -1561634.591% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | -487036.808% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | -674712.885% |
| Todos Medical Ltd. | 33 Million USD | -11686.007% |